This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Atrion Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

David Battat

İcra Kurulu Başkanı

US$924.5k

Toplam tazminat

CEO maaş yüzdesi	77.7%
CEO görev süresi	17.3yrs
CEO sahipliği	5.4%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	18.5yrs

Son yönetim güncellemeleri

Recent updates

There May Be Some Bright Spots In Atrion's (NASDAQ:ATRI) Earnings

May 22

Atrion Corporation Is Overvalued For The Direction Fundamentals Are Heading

Mar 24

Subdued Growth No Barrier To Atrion Corporation (NASDAQ:ATRI) With Shares Advancing 25%

Mar 23

CEO Tazminat Analizi

David Battat'un ücretlendirmesi Atrion'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	US$13m
Mar 31 2024	n/a	n/a	US$19m
Dec 31 2023	US$924k	US$718k	US$19m
Sep 30 2023	n/a	n/a	US$21m
Jun 30 2023	n/a	n/a	US$27m
Mar 31 2023	n/a	n/a	US$30m
Dec 31 2022	US$2m	US$620k	US$35m
Sep 30 2022	n/a	n/a	US$35m
Jun 30 2022	n/a	n/a	US$34m
Mar 31 2022	n/a	n/a	US$34m
Dec 31 2021	US$2m	US$620k	US$33m
Sep 30 2021	n/a	n/a	US$32m
Jun 30 2021	n/a	n/a	US$31m
Mar 31 2021	n/a	n/a	US$31m
Dec 31 2020	US$2m	US$620k	US$32m
Sep 30 2020	n/a	n/a	US$33m
Jun 30 2020	n/a	n/a	US$35m
Mar 31 2020	n/a	n/a	US$36m
Dec 31 2019	n/a	n/a	US$37m
Sep 30 2019	n/a	n/a	US$36m
Jun 30 2019	n/a	n/a	US$36m
Mar 31 2019	n/a	n/a	US$35m
Dec 31 2018	US$2m	US$620k	US$34m
Sep 30 2018	n/a	n/a	US$35m
Jun 30 2018	n/a	n/a	US$34m
Mar 31 2018	n/a	n/a	US$35m
Dec 31 2017	US$4m	US$620k	US$37m

Tazminat ve Piyasa: David 'nin toplam tazminatı ($USD 924.46K ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 3.18M ).

Tazminat ve Kazançlar: David 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

David Battat (54 yo)

17.3yrs

Görev süresi

US$924,464

Tazminat

Mr. David A. Battat has been the Chief Executive Officer of ATRION Corp. since May 26, 2011 and has been its President since May 2007. Mr. Battat has been the President of Halkey-Roberts Corporation, a sub...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Emile Battat	Executive Chairman	37.6yrs	US$632.56k	8.56% $ 69.3m
John Stupp	Independent Director	39.6yrs	US$207.86k	1.63% $ 13.2m
Ronald Spaulding	Independent Lead Director	18.5yrs	US$204.00k	0.15% $ 1.2m
Preston Athey	Independent Director	7.4yrs	US$142.03k	0.078% $ 629.2k
Jeannette Bankes	Independent Director	less than a year	US$100.96k	0.011% $ 85.6k

18.5yrs

Ortalama Görev Süresi

74yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ATRI 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 18.5 yıldır).

This company has been acquired

Atrion Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

President & CEO exercised options and sold US$141k worth of stock

Atrion Corporation, Annual General Meeting, May 21, 2024

Independent Director recently bought US$96k worth of stock

President & CEO recently bought US$90k worth of stock

Atrion Corporation Announces Election of Jeannette Bankes as Director

Executive Chairman exercised options and sold US$176k worth of stock

Recent updates

Atrion Corporation(NasdaqGS:ATRI) dropped from NASDAQ Composite Index

Nordson Medical Corporation completed the acquisition of Atrion Corporation (NasdaqGS:ATRI) from a group of shareholders.

Second quarter 2024 earnings released: EPS: US$0.23 (vs US$3.73 in 2Q 2023)

President & CEO exercised options and sold US$141k worth of stock

Upcoming dividend of US$2.20 per share

Nordson Medical Corporation entered into an agreement to acquire Atrion Corporation (NasdaqGS:ATRI) for approximately $820 million.

First quarter dividend of US$2.20 announced

There May Be Some Bright Spots In Atrion's (NASDAQ:ATRI) Earnings

Atrion Corporation Declares Quarterly Cash Dividend, Payable on June 28, 2024

First quarter 2024 earnings released: EPS: US$1.59 (vs US$1.98 in 1Q 2023)

Atrion Corporation Provides Production Guidance for the Third Quarter of 2024

Atrion Corporation, Annual General Meeting, May 21, 2024

Investor sentiment improves as stock rises 16%

Atrion Corporation Is Overvalued For The Direction Fundamentals Are Heading

Subdued Growth No Barrier To Atrion Corporation (NASDAQ:ATRI) With Shares Advancing 25%

Investor sentiment improves as stock rises 23%

Upcoming dividend of US$2.20 per share

Fourth quarter dividend of US$2.20 announced

Investor sentiment improves as stock rises 17%

Here's Why Atrion (NASDAQ:ATRI) Can Manage Its Debt Responsibly

Atrion Corporation's (NASDAQ:ATRI) 26% Share Price Surge Not Quite Adding Up

Investor sentiment improves as stock rises 16%

Independent Director recently bought US$96k worth of stock

Upcoming dividend of US$2.20 per share at 3.0% yield

President & CEO recently bought US$90k worth of stock

Atrion Corporation Declares Quarterly Cash Dividend, Payable on December 15, 2023

New minor risk - Profit margin trend

Third quarter 2023 earnings released: EPS: US$1.67 (vs US$4.95 in 3Q 2022)

Investor sentiment deteriorates as stock falls 17%

Atrion Corporation Announces Election of Jeannette Bankes as Director

Atrion (NASDAQ:ATRI) Seems To Use Debt Quite Sensibly

Upcoming dividend of US$2.20 per share at 1.9% yield

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: US$3.73 (vs US$5.21 in 2Q 2022)

Atrion (NASDAQ:ATRI) Will Want To Turn Around Its Return Trends

Executive Chairman exercised options and sold US$176k worth of stock

Upcoming dividend of US$2.15 per share at 1.6% yield

Atrion Corporation Declares Quarterly Dividend, Payable on June 30, 2023

First quarter 2023 earnings released: EPS: US$1.98 (vs US$4.72 in 1Q 2022)

Be Wary Of Atrion (NASDAQ:ATRI) And Its Returns On Capital

Upcoming dividend of US$2.15 per share at 1.4% yield

Full year 2022 earnings released: EPS: US$19.59 (vs US$18.22 in FY 2021)

Investor sentiment deteriorates as stock falls 17%

Upcoming dividend of US$2.15 per share

Insufficient new directors

Atrion Corporation Declares Quarterly Cash Dividend, Payable on December 15, 2022

Atrion Corporation Revises Earnings Guidance for the Second Half of 2022

Third quarter 2022 earnings released: EPS: US$4.95 (vs US$4.59 in 3Q 2021)

Atrion Corporation Revises Earnings Guidance for the Second Half of 2022

Insufficient new directors

Atrion (NASDAQ:ATRI) May Have Issues Allocating Its Capital

Atrion Corporation Announces Resignation of Maria Sainz from the Board of Directors, Effective from October 21, 2022

Atrion: Attractively Priced For Exposure To Defensive Healthcare

Upcoming dividend of US$2.15 per share

CFO, VP exercised options and sold US$51k worth of stock

Atrion's (NASDAQ:ATRI) Upcoming Dividend Will Be Larger Than Last Year's

Atrion Corporation Announces CFO Changes

Atrion Corporation Increases Quarterly Cash Dividend, Payable on September 30, 2022

Atrion raises dividend 10.3% to $2.15/share

Second quarter 2022 earnings released: EPS: US$5.21 (vs US$4.89 in 2Q 2021)

Some Investors May Be Worried About Atrion's (NASDAQ:ATRI) Returns On Capital

Executive Chairman exercised options and sold US$582k worth of stock

Atrion Corporation Announces Jeffery Strickland Intends to Retire as Secretary and Treasurer Effective March 3, 2023

Upcoming dividend of US$1.95 per share

CFO, VP exercised options and sold US$79k worth of stock

Atrion Corporation Declares Quarterly Cash Dividend, Payable on June 30, 2022

Atrion Corporation Declares Quarterly Cash Dividend, Payable on June 30, 2022

First quarter 2022 earnings released: EPS: US$4.72 (vs US$4.23 in 1Q 2021)